Moderna Inks Latin America Deal in Bid to Expand its Reach (1)

Feb. 23, 2022, 5:23 PM UTC

Moderna Inc. has signed a deal with a Uruguayan pharmaceutical company in a bid to expand its reach across Latin America.

The Covid-19 vaccine maker announced the distribution deal Tuesday with Adium Pharma SA to market the shots in 18 countries in the region including Brazil and Mexico. The shots will be supplied from Moderna’s plants in the U.S. and Europe, said Roman Saglio, head of commercial alliances for Latin America.

The move follows similar announcements from the company in Europe and in Asia as it ramps up deliveries of its messenger RNA vaccine across the globe. Moderna will ...

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.